Clinical Trial Update: Creatine for Depressed Male and Female Methamphetamine Users [Phase 3]

View source ↗

Summary

Phase 3 clinical trial is evaluating creatine for depression and methamphetamine use disorder, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Major Depressive Disorder
• Methamphetamine Use Disorder

Drugs mentioned

• Creatine (creatine)

Snippet

Sponsor: Montana State University | Conditions: Depression, Anxiety | Phase 3 | Status: RECRUITING